Meeder Asset Management’s Alaunos Therapeutics TCRT Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q4 | – | Sell |
-4
| Closed | -$82 | – | 565 |
|
2023
Q3 | $82 | Sell |
4
-29
| -88% | -$595 | ﹤0.01% | 478 |
|
2023
Q2 | $2.5K | Hold |
33
| – | – | ﹤0.01% | 477 |
|
2023
Q1 | $3.09K | Sell |
33
-34
| -51% | -$3.18K | ﹤0.01% | 545 |
|
2022
Q4 | $6.49K | Sell |
67
-26
| -28% | -$2.52K | ﹤0.01% | 685 |
|
2022
Q3 | $24K | Hold |
93
| – | – | ﹤0.01% | 1052 |
|
2022
Q2 | $17K | Sell |
93
-8
| -8% | -$1.46K | ﹤0.01% | 1207 |
|
2022
Q1 | $9K | Buy |
+101
| New | +$9K | ﹤0.01% | 1598 |
|
2021
Q4 | – | Sell |
-36
| Closed | -$10K | – | 2218 |
|
2021
Q3 | $10K | Hold |
36
| – | – | ﹤0.01% | 1672 |
|
2021
Q2 | $14K | Hold |
36
| – | – | ﹤0.01% | 1592 |
|
2021
Q1 | $19K | Buy |
+36
| New | +$19K | ﹤0.01% | 1425 |
|
2020
Q4 | – | Sell |
-49
| Closed | -$19K | – | 2213 |
|
2020
Q3 | $19K | Buy |
+49
| New | +$19K | ﹤0.01% | 1188 |
|
2019
Q1 | – | Sell |
-4
| Closed | -$1K | – | 1845 |
|
2018
Q4 | $1K | Hold |
4
| – | – | ﹤0.01% | 1652 |
|
2018
Q3 | $2K | Buy |
+4
| New | +$2K | ﹤0.01% | 1445 |
|
2017
Q2 | – | Sell |
-15
| Closed | -$15K | – | 1865 |
|
2017
Q1 | $15K | Sell |
15
-5
| -25% | -$5K | ﹤0.01% | 770 |
|
2016
Q4 | $16K | Buy |
+20
| New | +$16K | ﹤0.01% | 684 |
|